A Phase 3, Randomized, Double-Blind Study of Pembrolizumab versus placebo in combination with adjuvant chemotherapy with or without radiotherapy for the treatment of newly diagnosed High-Risk Endometrial Cancer after surgery with curative Intent
Trial Number
2020-003424-17 (EudraCT Number)Contact Person
Status
Closed to Recruitment
Disease Site
Endometrial
Lead Cooperative Group
Participating Groups
GOG-F
AGO-AUST
CEEGOG
NSGO-CTU
GINECO
AGO
ISGO
MITO
MaNGO
GEICO
NCRI
KGOG
GOTIC